Van Hulzen Asset Management LLC grew its stake in Colgate-Palmolive (NYSE:CL) by 8.1% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 42,502 shares of the company’s stock after purchasing an additional 3,200 shares during the period. Van Hulzen Asset Management LLC’s holdings in Colgate-Palmolive were worth $3,096,000 at the end of the most recent quarter.
A number of other institutional investors also recently added to or reduced their stakes in CL. Jacobi Capital Management LLC raised its stake in shares of Colgate-Palmolive by 125.5% during the 3rd quarter. Jacobi Capital Management LLC now owns 1,443 shares of the company’s stock worth $104,000 after buying an additional 803 shares during the period. Krilogy Financial LLC raised its stake in shares of Colgate-Palmolive by 23.0% during the 2nd quarter. Krilogy Financial LLC now owns 1,547 shares of the company’s stock worth $115,000 after buying an additional 289 shares during the period. Harbour Capital Advisors LLC acquired a new position in shares of Colgate-Palmolive during the 1st quarter worth approximately $121,000. Hanson & Doremus Investment Management raised its stake in shares of Colgate-Palmolive by 4.5% during the 2nd quarter. Hanson & Doremus Investment Management now owns 1,630 shares of the company’s stock worth $121,000 after buying an additional 70 shares during the period. Finally, Captrust Financial Advisors acquired a new position in shares of Colgate-Palmolive during the 2nd quarter worth approximately $122,000. Institutional investors and hedge funds own 72.96% of the company’s stock.
Shares of Colgate-Palmolive (CL) traded down $0.43 on Wednesday, hitting $74.24. The company’s stock had a trading volume of 5,458,859 shares, compared to its average volume of 3,640,000. The firm has a market cap of $65,190.00, a P/E ratio of 32.56, a PEG ratio of 3.02 and a beta of 0.81. The company has a quick ratio of 0.34, a current ratio of 0.47 and a debt-to-equity ratio of 24.42. Colgate-Palmolive has a twelve month low of $64.34 and a twelve month high of $77.91.
Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Friday, January 26th. The company reported $0.75 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.75. The business had revenue of $3.89 billion during the quarter, compared to analysts’ expectations of $3.92 billion. Colgate-Palmolive had a return on equity of 1,716.69% and a net margin of 13.10%. The company’s revenue was up 4.6% compared to the same quarter last year. During the same period in the prior year, the business posted $0.75 EPS. equities analysts expect that Colgate-Palmolive will post 3.21 EPS for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Thursday, February 15th. Stockholders of record on Tuesday, January 23rd will be issued a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.16%. The ex-dividend date of this dividend is Monday, January 22nd. Colgate-Palmolive’s dividend payout ratio is presently 70.18%.
Several research analysts recently commented on the company. Zacks Investment Research downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Tuesday, October 17th. KeyCorp reissued a “hold” rating on shares of Colgate-Palmolive in a research note on Monday, October 16th. Macquarie raised Colgate-Palmolive from a “neutral” rating to an “outperform” rating and set a $81.00 price objective for the company in a research note on Tuesday, December 19th. BNP Paribas downgraded Colgate-Palmolive from an “outperform” rating to an “underperform” rating in a research note on Tuesday. Finally, Citigroup increased their price objective on Colgate-Palmolive from $75.00 to $80.00 and gave the company a “neutral” rating in a research note on Tuesday. Three analysts have rated the stock with a sell rating, twelve have assigned a hold rating and five have assigned a buy rating to the company’s stock. Colgate-Palmolive has a consensus rating of “Hold” and an average price target of $77.48.
In related news, insider Jennifer Daniels sold 902 shares of the firm’s stock in a transaction dated Tuesday, January 9th. The stock was sold at an average price of $75.82, for a total transaction of $68,389.64. Following the completion of the transaction, the insider now directly owns 37,788 shares in the company, valued at approximately $2,865,086.16. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, COO Justin Skala sold 126,393 shares of the firm’s stock in a transaction dated Thursday, November 9th. The shares were sold at an average price of $72.97, for a total value of $9,222,897.21. Following the transaction, the chief operating officer now owns 262,361 shares of the company’s stock, valued at $19,144,482.17. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 181,950 shares of company stock valued at $13,237,385. Company insiders own 1.02% of the company’s stock.
TRADEMARK VIOLATION WARNING: This report was originally published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this report on another website, it was illegally stolen and republished in violation of US and international trademark & copyright laws. The original version of this report can be accessed at https://www.dispatchtribunal.com/2018/01/31/colgate-palmolive-cl-shares-bought-by-van-hulzen-asset-management-llc.html.
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.